Guidelines for the Application of Human Papillomavirus (HPV) Preventive Vaccines for Cervical Cancer (2025 Edition)
Abstract：1 Background
Cervical cancer is mainly caused by persistent infection with high-risk human papillomavirus (HPV). HPV preventive vaccines have played an important role in preventing cervical cancer and precancerous lesions, and have been included in the national immunization program. The Cervical Cancer Professional Committee of the Chinese Anti-Cancer Association has organized experts in related fields to develop this application guideline based on evidence-based medical evidence and considering China's actual situation. The recommendation levels and their meanings are shown in Table 1.
Keywords：cervical cancerHPVvaccineguideline
Publication Date：2025-10-02
Online Publishing Date：2025-11-19(First online date of this platform, not the publication date of the document)
Pages：14( 990-1003 )